ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker
Patrícia Regina Manzine(Universidade Federal de São Carlos), Márcia R. Cominetti(Universidade Federal de São Carlos), Elena Marcello(University of Milan), Amanda Cano(Biomedical Research Networking Center on Neurodegenerative Diseases), Miren Ettcheto(Universitat de Barcelona), Silvia Pelucchi(University of Milan), Jordi Olloquequi(University of Chile), Kristina Endres(Johannes Gutenberg University Mainz), Oriol Busquets(Biomedical Research Networking Center on Neurodegenerative Diseases), Antoni Camins(Biomedical Research Networking Center on Neurodegenerative Diseases), Mónica Di Luca(University of Milan)
Cited by 83
Related Papers
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
|Nanomaterials|2020|1.4k
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
|Journal of Controlled Release|2019|330
Microemulsions and Nanoemulsions in Skin Drug Delivery
|Bioengineering|2022|291
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
|Journal of Nanobiotechnology|2018|284
Current Applications of Nanoemulsions in Cancer Therapeutics
|Nanomaterials|2019|267